Join the movement
We can change the trajectory of colorectal cancer together.
Seeking collaborative researchers
Project Cure CRC is a multi-faceted effort combining innovative research and cutting-edge venture philanthropy. Ending colorectal cancer will take all of us, in collaboration, driving urgently toward cures.
Direct funding
Project Cure CRC’s fund for breakthoughs supports science from a wide variety of researchers.
Early-Career Investigator Award
Supports early-career faculty with innovative ideas in CRC research, providing up to $200,000 over two years for original preclinical, translational, or early clinical projects.
Senior Investigator Award
Funds transformative research to advance CRC therapies, offering up to $2,000,000 over two years for senior investigators proposing localized or metastatic CRC projects.
Pilot Award
Encourages high-risk, high-reward CRC research with clear hypotheses, providing up to $200,000 over two years to establish proof-of-concept.
Team Science Award
Supports collaborative, multidisciplinary CRC research teams with up to $4,000,000 over two years to drive curative science and innovation.
Opportunistic Award
Provides up to $500,000 for small startup companies (with one or less rounds of funding) conducting novel CRC research over one year to advance curative science.
Strategic Award
Funds Phase II/III clinical trials by small biotech/pharma companies, offering up to $5,000,000 per year to address unmet clinical needs.
Innovators wanted
Project Cure CRC prioritizes high-risk/high-reward proposals that fast-track research toward curative solutions, with a strong preference for collaborative and public-private partnerships.
Sponsors
Up Next
Funded researchTop resources
Be heard this November: The Cancer Promise
Learn about The Cancer Promise initiative and how political candidates can pledge to support cancer research, prevention, and care policies. Make your voice heard this election.
Alliance supports the Clinical Trials Modernization Act
This bipartisan legislation aims to improve participation in clinical trials by addressing major barriers such as non-medical expenses, trial location accessibility, diverse participation, and financial implications for patients.
23andMe and the Alliance team up on cancer research
The collaboration aims to raise awareness, encourage screening, and help people better understand their risks.